Biology and experimental therapy of malignant glioma

W.Wick Wolfgang Wick

Department of Neurooncology
University Clinic of Heidelberg
INF 400
69120 Heidelberg
Germany
 
Phone:  +49-6221-567075
Fax:  +49-6221-567554
Email:  wolfgang.wick@med.uni-heidelberg.de
Website:  www.klinikum.uni-heidelberg.de/neuroonkologie

Research Summary

The putative origin of malignant gliomas from neuronal or other brain-derived stem cells challenges several aspects of current concepts in brain tumor biology and therapeutic approaches. Further key propensities of gliomas, such as migration and invasiveness as well as angiogenesis need further molecular clarification. Consequent experimental therapies involve vaccination approaches and delivery by hematopoietic and mesenchymal stem cells.

Structure of the Group

Group Leader:  Wolfgang Wick
   
Scientists:  Jonas Blaes, Zhen Dong, Christiane Grimm, Dieter Lemke, Yunxiang Liao, Sarah Löw, Mathias Oswald, Phillip-Niclas Pfenning, Maximilian Schliesser, Markus Weiler, Elisa Weiss, Benedikt Wiestler
Undergraduates:  Elena Czink, Tobias Kessler, Hans-Werner Pledl
Technicians:  Miriam Gramlich, Ann-Catherine Klein, Petra Rübmann

 

Editor: Email
Latest Revision: 2015-03-19
zum Seitenanfang/up